| Independent Reports (Showing 1 to 10 of 29) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
More Info |
| 22-May-13 | New Constructs, LLC | N/A | VRTX: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | View Abstract |
| 22-May-13 | Stock Traders Daily | Thomas H Kee Jr. | Trading Report for (VRTX). A detailed report, including free correlated market analysis, and updates. | 5 | $57.50 | View Abstract |
| 21-May-13 | Stock Traders Daily | Thomas H Kee Jr. | The Investment Rate - a measure of investment demand. | 43 | $494.50 | View Abstract |
| 20-May-13 | Pechala's Reports | Lubomir Pechala | VERTEX PHARMACEUTICALS INC (VRTX) - REPORT FOR ACTIVE TRADERS | 1 | $25 | View Abstract |
| 20-May-13 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | View Abstract |
| 18-May-13 | S&P Capital IQ – STARS Reports | N/A | Vertex Pharmaceuticals | 10 | $115 | View Abstract |
| 18-May-13 | Pechala's Reports | Frantisek Pechala | VERTEX PHARMACEUTICALS INC (VRTX) 12-months forecast | 1 | $15 | View Abstract |
| 17-May-13 | Directors Deals Ltd. | Company Snapshot | Company Snapshot - Vertex Pharmaceutical Inc | 1 | $11.50 | View Abstract |
| 17-May-13 | Ford Investor Services, Inc. | N/A | Value Graph: VERTEX PHARMACEU -- VRTX | 1 | $11.50 | View Abstract |
| 17-May-13 | Ford Investor Services, Inc. | N/A | Industry Value Graph: CELG , ENZN , LIFE , ONTY , VRTX -- DRUGS | 3 | $34.50 | View Abstract |